Study of HL-085 in NRAS Mutant Advanced Melanoma
Clinical trial NCT03973151 · COMPLETED
Trial details
- NCT number
- NCT03973151
- Sponsor
- Shanghai Kechow Pharma, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-01
- Primary completion
- 2021-01-18
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.